Antifungal susceptibilities to amphotericin B, triazoles and echinocandins of 77 clinical isolates of cryptic Aspergillus species in multicenter surveillance in Korea

Eun Jeong Won; Jong Hee Shin; Soo Hyun Kim; Min Ji Choi; Seung A. Byun; Mi Na Kim; Wee Gyo Lee; Kyungwon Lee; Young Uh; Myung Geun Shin; Soon Pal Suh

doi:10.1093/mmy/myx067

Antifungal susceptibilities to amphotericin B, triazoles and echinocandins of 77 clinical isolates of cryptic Aspergillus species in multicenter surveillance in Korea

Eun Jeong Won, Jong Hee Shin, Soo Hyun Kim, Min Ji Choi, Seung A. Byun, Mi Na Kim, Wee Gyo Lee, Kyungwon Lee, Young Uh, Myung Geun Shin, Soon Pal Suh

Department of Laboratory Medicine

Research output: Contribution to journal › Article › peer-review

10 Citations (Scopus)

Abstract

We investigated the in vitro antifungal susceptibilities of cryptic Aspergillus species from nine Korean hospitals. Based on the CLSI epidemiological cutoff values, resistance rates to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin were as follows: A. awamori (34 isolates; all 0%), A. tubingensis (22; 0%, 4.5%, 0%, 0%, and 0%, respectively), A. sydowii (16; 0%, 6.3%, 0%, 0%, and 6.3%), A. lentulus (2; 50%, 0%, 100%, 50%, and 0%), and A. tamarii (2; all 0%). A. calidoustus (one isolate) showed resistance to multiple drugs. Thus, cryptic species identification can be mandatory for clinically important Aspergillus isolates, with their susceptibility data.

Original language	English
Pages (from-to)	501-505
Number of pages	5
Journal	Medical mycology
Volume	56
Issue number	4
DOIs	https://doi.org/10.1093/mmy/myx067
Publication status	Published - 2018 Jun 1

Bibliographical note

Funding Information:
This research was supported by a fund (2015E4400100) by Research of Korea Centers for Disease Control and Prevention, and the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (NRF-2016R1A2B4008181; NRF- 2016R1C1B1009746).

Publisher Copyright:
© 2018 The Author 2017. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

All Science Journal Classification (ASJC) codes

Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/mmy/myx067

Cite this

Won, E. J., Shin, J. H., Kim, S. H., Choi, M. J., Byun, S. A., Kim, M. N., Lee, W. G., Lee, K., Uh, Y., Shin, M. G., & Suh, S. P. (2018). Antifungal susceptibilities to amphotericin B, triazoles and echinocandins of 77 clinical isolates of cryptic Aspergillus species in multicenter surveillance in Korea. Medical mycology, 56(4), 501-505. https://doi.org/10.1093/mmy/myx067

@article{8923ecf915144f6c8d3b2c97906efaed,

title = "Antifungal susceptibilities to amphotericin B, triazoles and echinocandins of 77 clinical isolates of cryptic Aspergillus species in multicenter surveillance in Korea",

abstract = "We investigated the in vitro antifungal susceptibilities of cryptic Aspergillus species from nine Korean hospitals. Based on the CLSI epidemiological cutoff values, resistance rates to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin were as follows: A. awamori (34 isolates; all 0%), A. tubingensis (22; 0%, 4.5%, 0%, 0%, and 0%, respectively), A. sydowii (16; 0%, 6.3%, 0%, 0%, and 6.3%), A. lentulus (2; 50%, 0%, 100%, 50%, and 0%), and A. tamarii (2; all 0%). A. calidoustus (one isolate) showed resistance to multiple drugs. Thus, cryptic species identification can be mandatory for clinically important Aspergillus isolates, with their susceptibility data.",

author = "Won, {Eun Jeong} and Shin, {Jong Hee} and Kim, {Soo Hyun} and Choi, {Min Ji} and Byun, {Seung A.} and Kim, {Mi Na} and Lee, {Wee Gyo} and Kyungwon Lee and Young Uh and Shin, {Myung Geun} and Suh, {Soon Pal}",

note = "Funding Information: This research was supported by a fund (2015E4400100) by Research of Korea Centers for Disease Control and Prevention, and the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (NRF-2016R1A2B4008181; NRF- 2016R1C1B1009746). Publisher Copyright: {\textcopyright} 2018 The Author 2017. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.",

year = "2018",

month = jun,

day = "1",

doi = "10.1093/mmy/myx067",

language = "English",

volume = "56",

pages = "501--505",

journal = "Medical mycology",

issn = "1369-3786",

publisher = "Informa Healthcare",

number = "4",

}

TY - JOUR

T1 - Antifungal susceptibilities to amphotericin B, triazoles and echinocandins of 77 clinical isolates of cryptic Aspergillus species in multicenter surveillance in Korea

AU - Won, Eun Jeong

AU - Shin, Jong Hee

AU - Kim, Soo Hyun

AU - Choi, Min Ji

AU - Byun, Seung A.

AU - Kim, Mi Na

AU - Lee, Wee Gyo

AU - Lee, Kyungwon

AU - Uh, Young

AU - Shin, Myung Geun

AU - Suh, Soon Pal

N1 - Funding Information: This research was supported by a fund (2015E4400100) by Research of Korea Centers for Disease Control and Prevention, and the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (NRF-2016R1A2B4008181; NRF- 2016R1C1B1009746). Publisher Copyright: © 2018 The Author 2017. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - We investigated the in vitro antifungal susceptibilities of cryptic Aspergillus species from nine Korean hospitals. Based on the CLSI epidemiological cutoff values, resistance rates to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin were as follows: A. awamori (34 isolates; all 0%), A. tubingensis (22; 0%, 4.5%, 0%, 0%, and 0%, respectively), A. sydowii (16; 0%, 6.3%, 0%, 0%, and 6.3%), A. lentulus (2; 50%, 0%, 100%, 50%, and 0%), and A. tamarii (2; all 0%). A. calidoustus (one isolate) showed resistance to multiple drugs. Thus, cryptic species identification can be mandatory for clinically important Aspergillus isolates, with their susceptibility data.

AB - We investigated the in vitro antifungal susceptibilities of cryptic Aspergillus species from nine Korean hospitals. Based on the CLSI epidemiological cutoff values, resistance rates to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin were as follows: A. awamori (34 isolates; all 0%), A. tubingensis (22; 0%, 4.5%, 0%, 0%, and 0%, respectively), A. sydowii (16; 0%, 6.3%, 0%, 0%, and 6.3%), A. lentulus (2; 50%, 0%, 100%, 50%, and 0%), and A. tamarii (2; all 0%). A. calidoustus (one isolate) showed resistance to multiple drugs. Thus, cryptic species identification can be mandatory for clinically important Aspergillus isolates, with their susceptibility data.

UR - http://www.scopus.com/inward/record.url?scp=85057899176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057899176&partnerID=8YFLogxK

U2 - 10.1093/mmy/myx067

DO - 10.1093/mmy/myx067

M3 - Article

C2 - 28992138

AN - SCOPUS:85057899176

SN - 1369-3786

VL - 56

SP - 501

EP - 505

JO - Medical mycology

JF - Medical mycology

IS - 4

ER -

Antifungal susceptibilities to amphotericin B, triazoles and echinocandins of 77 clinical isolates of cryptic Aspergillus species in multicenter surveillance in Korea

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this